ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,964Medicare Part D Prescriptions Filled, Including Refills

Rank: 476 out of 2061

$701K Total Retail Price of All Prescriptions

Rank: 359 out of 2061

611 Patients Receiving at Least One Drug in Part D
70%Patients 65 Years and Older
64% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Ohio
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 611 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

4% of this provider’s 611 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 6,605 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$70 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Ohio
SIMVASTATIN 529 381 1 1
LISINOPRIL 426 350 2 2
LEVOTHYROXINE SODIUM 312 245 3 3
FUROSEMIDE 283 217 4 6
OMEPRAZOLE 242 163 5 5
GABAPENTIN 213 135 6 15
CYMBALTA 189 152 7 59
METFORMIN HCL 172 142 8 9
METOPROLOL TARTRATE 171 141 9 7
TRAMADOL HCL 157 97 10 18
CARVEDILOL 140 121 11 22
FENOFIBRATE 140 114 11 65
PROAIR HFA 139 31 13 40
WARFARIN SODIUM 137 120 14 11
NAMENDA 137 104 14 37
AMLODIPINE BESYLATE 128 112 16 4
ATORVASTATIN CALCIUM 118 82 17 8
SEROQUEL XR 110 26 18 282
CITALOPRAM HBR 103 29 19 20
PRAVASTATIN SODIUM 102 66 20 14
SERTRALINE HCL 102 77 20 21
KLOR-CON M20 101 72 22 47
TOPIRAMATE 94 50 23 190
LISINOPRIL-HYDROCHLOROTHIAZIDE 91 78 24 27
SPIRIVA 89 52 25 63
GLIMEPIRIDE 89 75 25 33
LOSARTAN POTASSIUM 83 68 27 17
TAMSULOSIN HCL 81 64 28 30
MIRTAZAPINE 80 59 29 46
RISPERIDONE 79 35 30 66
ATENOLOL 79 79 30 13
OLANZAPINE 75 17 32 132
QUETIAPINE FUMARATE 72 14 33 72
METOPROLOL SUCCINATE 70 49 34 19
DONEPEZIL HCL 69 40 35 24
POTASSIUM CHLORIDE 69 41 35 16
ALLOPURINOL 69 45 35 28
TRICOR 68 39 38 128
GLIPIZIDE 67 58 39 55
HYDROCHLOROTHIAZIDE 67 39 39 12
TRAZODONE HCL 64 30 41 39
HYDROCODONE-ACETAMINOPHEN 61 48 S3 42 10
LOVASTATIN 59 57 43 35
CARBAMAZEPINE 59 47 43 187
AZITHROMYCIN 58 45 45 34
ABILIFY 58 30 45 160
MELOXICAM 58 38 45 44
LOSARTAN-HYDROCHLOROTHIAZIDE 57 41 48 50
EXELON 57 56 48 94
AMITRIPTYLINE HCL 55 23 R 50 89
DIVALPROEX SODIUM 55 27 50 74
LANTUS 55 31 50 48
CRESTOR 51 23 53 31
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 4, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.